Prometheus Biosciences, Inc.
RXDXDelisted Jun 16, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001718852
Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Prometheus Biosciences, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 220 | 1 | 2 | −217 |
| Shares | 40.5M | 8 | 18.5K | −40.5M (−100.0%) |
| Value | $4.35B | $859 | $1.98M | −$4.35B (−100.0%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Prometheus Biosciences, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (217)
Institutions that held Prometheus Biosciences, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
Showing the largest 100 of 217 by value.
Not filed for Q2 2023 yet (1)
Institutions that held Prometheus Biosciences, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Harvest Group Wealth Management, LLC | 8 | $859 |